Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Osteosarcoma 3Neuroblastoma 3Breast Neoplasms 3Sarcoma, Ewing 2Rhabdomyosarcoma 2With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive 1Nerve Sheath Neoplasms 1Neoplasm Metastasis 1Myoepithelioma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leiomyosarcoma 1Hodgkin Disease 1Giant Cell Tumor of Bone 1Desmoplastic Small Round Cell Tumor 1Clear-cell metastatic renal cell carcinoma 1Chordoma 1Chondrosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Metastatic 1

Interventions

atezolizumab 3Specimen Handling 2spartalizumab 1selinexor 1sargramostim 1pembrolizumab 1pazopanib 1fludarabine 1cediranib 1cabozantinib 1atropine sulfate-diphenoxylate hydrochloride drug combination 1anlotinib 1Zoledronic Acid 1Warfarin 1Vitamin B 6 1Thyroxine 1Tablets 1Sunitinib 1Rosuvastatin Calcium 1Radiotherapy 1Radiation 1Pyridoxine 1Promethazine 1Prochlorperazine 1Petrolatum 1Midazolam 1Lorazepam 1Loperamide 1Immunoglobulin G 1Ifosfamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Alveolar Soft Part × Zoledronic Acid × 1 year × Clear all
NCT06625190 2026-03-11

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

University of Florida

Phase 1/2 Recruiting
27 enrolled
CNSSarcoma

Chordoma, Myoepithelioma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Nerve Sheath Neoplasms, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡